Fermi, which is organized as a real-estate investment trust, is worrying investors with the delay in closing the deal with its first tenant.

AtaiBeckley NV (NASDAQ:ATAI, ETR:9VC) is gaining analyst attention after Phase 2b results for its investigational therapy BPL-003 demonstrated rapid, meaningful, and durable antidepressant effects in treatment-resistant depression (TRD), reinforcing its potential as a differentiated psychedelic therapy. Jefferies highlighted that the data could influence dosing strategies and commercial positioning, given the single-dose durability and strong remission rates observed in the open-label extension (OLE).

SoftBank is out of Nvidia stock—but not the AI trade.

Investors Title saw a 31% surge in Q3 earnings and 6% revenue growth, fueled by increased real estate transactions and like-kind exchange services.

Endava plc ( DAVA ) Q1 2026 Earnings Call November 11, 2025 8:00 AM EST Company Participants Laurence Madsen John Cotterell - Founder, CEO & Director Mark Thurston - CFO & Director Conference Call Participants Bryan Bergin - TD Cowen, Research Division Margaret Nolan - William Blair & Company L.L.C., Research Division Christopher Svensson - Deutsche Bank AG, Research Division Antonio Jaramillo - Morgan Stanley, Research Division Yu Lee - Guggenheim Securities, LLC, Research Division Phani Kumar Kanumuri - HSBC Global Investment Research Puneet Jain - JPMorgan Chase & Co, Research Division Presentation Operator Good day and welcome to the …

The rapid proliferation of the edge IoT, AI data centers and automotive electrification, as well as the adoption of WiFi 6E and WiFi 7, is enhancing the prospects of SWKS and RFIL despite challenging macroeconomic conditions.

Streaming leaders Fox, fuboTV and Roku gain momentum as content output surges and global streaming adoption accelerates.

M&A activity is surging in infrastructure and real estate as regulatory and financial barriers ease, unlocking value in discounted public assets. Public REITs and infrastructure stocks trading below NAV are prime targets for private equity buyouts, often at significant premiums to market prices. Top buyout candidates include Global Medical REIT (GMRE) and Farmland Partners (FPI), both trading at deep discounts to their underlying asset values.

ATLANTA, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Trex Company, Inc. (“Trex” or “the Company”) (NYSE: TREX) complied with federal securities laws. On November 4, 2025, announced financial results for the third quarter of 2025, revealing lower-than-anticipated third quarter sales. The Company stated that it is working with its channel partners “to enable them to carry lower inventory levels heading into year-end, and we are adjusting our production accordingly.” Following this news, the price of the Company's stock dropped.

EHC shares fall 8% after Q3 results, as higher costs offset revenue gains, bed expansions and an upbeat 2025 outlook.

Iovance Biotherapeutics remains a Sell due to ongoing dilution risk, sub-consensus revenue, and only modest margin improvements. Q3 revenue landed in the base case at $68 million, missing estimates, while gross margin improved to 29.6% (≤30% adjusted for D&A). Management reaffirmed FY25 revenue guidance and extended cash runway to Q2 2027, but execution and credibility issues persist.

Axon Enterprise (NASDAQ:AXON) has transformed from a TASER-focused hardware maker into a comprehensive public safety technology platform. The company combines devices-such as TASER energy weapons, Axon Body cameras, Fleet vehicle systems, and sensor triggers-with cloud-based SaaS solutions like Axon Evidence for digital evidence management and emerging real-time AI tools like Axon Assistant.

PHILADELPHIA , Nov. 11, 2025 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against James Hardie Industries plc (NYSE: JHX) ("James Hardie" or the "Company") on behalf of investors who purchased James Hardie common stock and American Depositary Shares during the period of May 20, 2025 through August 18, 2025 (the "Class Period"). Investor Deadline: Investors who purchased James Hardie securities during the Class Period may, no later than December 23, 2025 , seek to be appointed as a lead plaintiff representative of the class.

Glaukos Corporation ( GKOS ) UBS Global Healthcare Conference 2025 November 11, 2025 10:15 AM EST Company Participants Alex Thurman - Senior VP & CFO Christopher Lewis - Vice President of Investor Relations & Corporate Affairs Conference Call Participants Danielle Antalffy - UBS Investment Bank, Research Division Presentation Danielle Antalffy UBS Investment Bank, Research Division Good morning, everyone. Thank you so much for joining.

TPR's Coach starts FY26 on a strong note, with 21% y/y revenue growth in Q1, customer growth worldwide and firm progress toward its $10B target.

AFRM shares jump 15% as Q1 earnings top estimates, driven by surging GMV, active merchants and repeat transactions.

Hecla Mining (HL) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Crown Holdings (CCK) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

EnerSys (ENS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

F&G Annuities & Life, Inc. (FG) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.